Heart failure patients with a condition called "heart block" derive significant benefit from cardiac resynchronization therapy (CRT), according to the results of the Block HF clinical trial, presented November 6 at the American Heart Association Scientific Sessions 2012 meeting in Los Angeles.read more
Fonte: esciencenews.com
Indique esta NotÃcia
Compartilhar